H.R. 1107

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1107 Referred in Senate (RFS)]

<DOC>
119th CONGRESS
1st Session
H. R. 1107

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

September 16, 2025

Received; read twice and referred to the Committee on Veterans' Affairs

_______________________________________________________________________

AN ACT

To amend title 38, United States Code, to authorize certain health care 
professionals employed by the Department of Veterans Affairs to 
deliver, distribute, or dispense to veterans certain controlled 
medications via telemedicine under certain conditions, and for other 
purposes.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Protecting Veteran Access to 
Telemedicine Services Act of 2025''.

SEC. 2. DELIVERY, DISTRIBUTION, AND DISPENSATION OF CONTROLLED 
MEDICATIONS BY COVERED DEPARTMENT OF VETERANS AFFAIRS 
HEALTH CARE PROFESSIONALS VIA TELEMEDICINE.

Subchapter III of chapter 17 of title 38, United States Code, is 
amended by adding at the end the following new section (and conforming 
the table of sections at the beginning of such chapter accordingly):
``Sec. 1730D. Delivery, distribution, and dispensation of controlled 
medications via telemedicine
``(a) In General.--Pursuant to section 1730C of this title and 
subject to the requirements of title II of the Comprehensive Drug Abuse 
Prevention and Control Act of 1970 (21 U.S.C. 801 et seq.), a covered 
health care professional may use telemedicine to deliver, distribute, 
or dispense to a patient eligible to receive medical treatment under 
this chapter a controlled substance that is a prescription drug as 
determined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
301 et seq.) regardless of whether such covered health care 
professional has conducted an in-person medical examination of such 
patient if--
``(1) such covered health care professional is--
``(A) authorized to prescribe the basic class of 
such controlled substance under an active, current, 
full, and unrestricted State license, registration, or 
certification; and
``(B) acting in the usual course of professional 
practice; and
``(2) such substance is delivered, distributed, or 
dispensed for a legitimate medical purpose.
``(b) Regulations.--The Secretary shall establish in regulations 
guidelines and a process for the delivery, distribution, and 
dispensation of a controlled substance pursuant to subsection (a).
``(c) Rule of Construction.--Nothing in this section may be 
construed to remove, limit, or otherwise affect any obligation of a 
covered health care professional under the Controlled Substances Act.
``(d) Definitions.-- In this section:
``(1) The terms `controlled substance', `deliver', 
`dispense', and `distribute' have the meanings given such terms 
in section 102 of the Controlled Substances Act, respectively.
``(2) The term `covered health care professional' means--
``(A) a health care professional who--
``(i) is an employee of the Department 
appointed under section 7306, 7401, 7405, 7406, 
or 7408 of this title or under title 5;
``(ii) is not a contractor of the 
Department;
``(iii) is authorized by the Secretary to 
provide health care under this chapter;
``(iv) is required to adhere to all 
standards for quality relating to the provision 
of health care in accordance with applicable 
policies of the Department;
``(v) has an active, current, full, and 
unrestricted license, registration, or 
certification or meet qualification standards 
set forth by the Secretary within a specified 
time frame; and
``(vi) with respect to a health care 
profession listed under section 7402(b) of this 
title, has the qualifications for such 
profession as set forth by the Secretary; and
``(B) a health professions trainee who--
``(i) is appointed under section 7405 of 
this title; and
``(ii) is under the clinical supervision of 
a health care professional described in 
subparagraph (A).''.

Passed the House of Representatives September 15, 2025.

Attest:

KEVIN F. MCCUMBER,

Clerk.